Clinical Trial Update: Mycophenolate Mofetil to Treat Wegener's Granulomatosis and Related Vascular Inflammatory Conditions [Phase 1]

View source ↗

Summary

A Phase 1 study of mycophenolate mofetil for granulomatosis with polyangiitis (Wegener's granulomatosis) and related vasculitic conditions has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Granulomatosis with Polyangiitis
• Vasculitis

Drugs mentioned

• CELLCEPT (mycophenolate mofetil hydrochloride)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Vasculitis, Wegener's Granulomatosis | Phase 1 | Status: COMPLETED